Table 6

Associations of patient and clinician characteristics with cluster membership

n=1724High versus NoneModerate versus  NoneLow versus None
RRR* (95% CI)RRR* (95% CI)RRR* (95% CI)
Patient factors
Age
 45–64111
 65–741.41 (1.07 to 1.84)0.45 (0.27 to 0.74)0.97 (0.69 to 1.37)
 75–841.13 (0.83 to 1.52)1.02 (0.65 to 1.60)1.42 (0.99 to 2.05)
 85+0.91 (0.56 to 1.47)1.56 (0.85 to 2.89)1.24 (0.69 to 2.23)
Gender
 Male111
 Female0.86 (0.69 to 1.07)1.03 (0.75 to 1.43)1.04 (0.80 to 1.36)
BMI category
 Normal111
 Overweight1.20 (0.91 to 1.60)0.57 (0.39 to 0.85)1.33 (0.93 to 1.90)
 Not recorded0.39 (0.27 to 0.56)0.52 (0.33 to 0.81)0.52 (0.33 to 0.82)
Diagnosis
 Recorded with joint pain only111
 OA diagnosis1.81 (1.41 to 2.32)0.55 (0.35 to 0.85)0.93 (0.68 to 1.29)
Site of OA
 Knee111
 Hip0.86 (0.66 to 1.14)1.14 (0.76 to 1.71)1.04 (0.75 to 1.44)
 Foot0.38 (0.24 to 0.60)0.73 (0.39 to 1.36)0.25 (0.13 to 0.51)
 Hand0.45 (0.30 to 0.70)1.18 (0.70 to 1.98)0.88 (0.56 to 1.39)
 Unspecified0.48 (0.30 to 0.80)0.85 (0.38 to 1.90)0.74 (0.41 to 1.34)
 Multiple1.13 (0.75 to 1.74)1.89 (0.99 to 3.59)0.65 (0.34 to 1.24)
Morbidity load†
BNF count
  0–4111
 5–90.95 (0.71 to 1.26)0.74 (0.50 to 1.11)0.75 (0.54 to 1.06)
 10+0.64 (0.47 to 0.87)0.55 (0.35 to 0.86)0.50 (0.35 to 0.73)
Number of OA consultations‡
 Multiple111
 Single0.43 (0.34 to 0.54)0.47 (0.33 to 0.66)0.45 (0.34 to 0.60)
Consulter status
 Repeat111
 New§1.12 (0.89 to 1.41)1.09 (0.76 to 1.55)1.18 (0.88 to 1.59)
Clinician factors
Clinician OA workload‡
 Below the median111
 Above the median2.90 (1.98 to 4.25)2.32 (1.33 to 4.03)1.46 (0.98 to 2.18)
  • *Relative risk ratio from multilevel multinomial regression (patients within initial clinician seen) adjusted for all presented covariates, None cluster is reference.

  • †Number of BNF subchapters from which prescription was made in previous 12 months.

  • ‡During 6-month period.

  • §No clinical OA consultations within the previous 12 months.

  • BMI, body mass index; BNF, British National Formulary; OA, osteoarthritis; RRR, relative risk ratios.